News | Breast Imaging | March 23, 2018

Average Breast Tumor Size Decreased Following Introduction of Screening

European researchers found tumor sizes increasing again since 2001, suggesting screening numbers may be declining again

Average Breast Tumor Size Decreased Following Introduction of Screening

March 23, 2018 — The average size of breast cancers at diagnosis decreased dramatically in the 1980s and 1990s following the introduction of screening, according to research presented at the 11th European Breast Cancer Conference, March 21-23 in Barcelona, Spain.

However, the new research also reveals a slight increase in the average size of breast tumors since 2001, perhaps as a result of a decrease in the number of women going for screening in the same period.

The researchers say it is not yet clear whether the recent increase in average tumor size will lead to more deaths from breast cancer in the coming years. But they point out that, in general, women with smaller tumors at diagnosis have a better chance of surviving the disease.

The research was carried out by Manon Jenkins, junior doctor, Louise Merker, surgical registrar, Nicholas Gallegos, consultant surgeon, and colleagues at Weston General Hospital in Bristol, U.K.

Jenkins said: "In general terms, small breast cancers have a better prognosis than larger ones. Screening aims to detect breast cancers before they are large enough for a woman to feel them. If that's the case then the number of large cancers among women who are offered screening should fall and mortality should also decline."

The study involved 386,454 women in the United States who were diagnosed with breast cancer between 1983 and 2014. Researchers categorized the women according to when they were diagnosed and their age at diagnosis. For each group they calculated the average tumor size, allowing them to see how this has changed in different age groups over the decades since screening was introduced.

The results show that average tumor size has decreased by 23 percent over the 32-year period, from 26mm to 20mm, but the trend was not consistent over the years and varied according to the women's ages.

When breast screening was introduced in the early 1980s the average size of breast cancers fell sharply. In women aged between 70 and 74, there was a decline in the average size of tumors of 27 percent but in women aged 85 and older, the decline was only 10 percent. Average tumor size in these older women, who are less likely to be screened, remains the highest.

From 2001 to 2014, researchers discovered an unexpected rise in average tumor size of between 3 percent (in the 75 to 79 age group) and 13 percent (in women aged 50 to 54 years).

Jenkins said: "Rates of breast cancer survival have been improving steadily thanks both to the introduction of screening and to improvements in treatments. What we don't know is which has played the biggest role in improving survival.

"This study suggests that by reducing tumor size, screening provides a platform from which breast cancer treatments might work more effectively.

"The recent increase in the average size of tumors may reflect a decline in rates of screening. If this is followed by a deterioration in breast cancer mortality rates it would strengthen the argument for screening programs to continue. On the other hand, if declining screening rates are not followed by a rise in breast cancer death rates, it probably signals that advances in treatment are the main reason for the improvement in breast cancer mortality."

The researchers hope to continue to study this group, comparing the stage of the women's tumors as well as looking in more detail at the elderly population.

Prof. Robert Mansel is chair of the 11th European Breast Cancer Conference and Emeritus Professor of Surgery at Cardiff University School of Medicine, U.K., and was not involved with the research. He said: "This study suggests there has been an overall decline in the average size of breast tumors since screening was introduced and we know that smaller tumors do lead to better prognosis.

"The research also shows that the decline has been less pronounced in older women and that, more recently, there has been a slight increase in average tumor size overall. Both of these are of concern, and we will need to continue to monitor breast screening programs and their impact on survival in women of all ages."

For more information: www.ecco-org.eu/ebcc

 

Related Content

RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.